Also known as: Betahistine hydrochloride
Betahistine is indicated for:
Irrespective of gender only Adults (18 years old or older)
Vertigo, tinnitus and hearing loss associated with Ménière’s syndrome.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 24-48 mg in 3 divided doses daily
Active ingredient Betahistine is contraindicated in the following cases:
No gender/age discrimination